Objective: The trajectory of cognitive de-cline in patients with late-onset Alzheimer’s disease varies widely. Genetic variations in CLU, PICALM, and CR1 are associated with Alzheimer’s disease, but it is unknown whether they exert their effects by altering cognitive trajectory in elderly individuals at risk for the disease. Method: The authors developed a Bayes-ian model to fit cognitive trajectories in a cohort of elderly subjects and test for genetic effects. They first validated the model’s ability to detect the previously established effects of APOE ε4 alleles on age at cognitive decline and of psychosi
Alzheimer's dementia commonly impacts the health of older adults and lacks any preventative therapy....
r r Abstract: Objective: Identify genetic factors associated with cognitive maintenance in late life...
Alzheimer's disease (AD) is a chronic progressive neurodegenerative disorder characterized by a...
Objective An Alzheimer’s disease (AD) diagnosis is preceded by a long period of cognitive decline. W...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
textabstractOBJECTIVE: To determine whether differences in genetic origin affect the clinical course...
Alzheimer's disease (AD) is a complex neurological disorder of uncertain aetiology, although substan...
Copyright © 2013 Perry G. Ridge et al. This is an open access article distributed under the Creative...
Copyright © 2015 Mariegold E. Wollam et al. This is an open access article distributed under the Cre...
Introduction: Variability exists in the disease trajectories of Alzheimer's disease (AD) patients. W...
BACKGROUND: The rate of cognitive decline in the early stages of Alzheimer's disease (AD) is variabl...
Aims: In the present study, we investigated whether apolipoprotein E (APOE) polymorphisms influenced...
Alzheimer’s disease · Dementia · Mild cognitive impairment Background: The clinical challenge in sub...
Context: Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nov...
ABSTRACT In recent years there have been major advances in the conceptualisation of dementia and cog...
Alzheimer's dementia commonly impacts the health of older adults and lacks any preventative therapy....
r r Abstract: Objective: Identify genetic factors associated with cognitive maintenance in late life...
Alzheimer's disease (AD) is a chronic progressive neurodegenerative disorder characterized by a...
Objective An Alzheimer’s disease (AD) diagnosis is preceded by a long period of cognitive decline. W...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
textabstractOBJECTIVE: To determine whether differences in genetic origin affect the clinical course...
Alzheimer's disease (AD) is a complex neurological disorder of uncertain aetiology, although substan...
Copyright © 2013 Perry G. Ridge et al. This is an open access article distributed under the Creative...
Copyright © 2015 Mariegold E. Wollam et al. This is an open access article distributed under the Cre...
Introduction: Variability exists in the disease trajectories of Alzheimer's disease (AD) patients. W...
BACKGROUND: The rate of cognitive decline in the early stages of Alzheimer's disease (AD) is variabl...
Aims: In the present study, we investigated whether apolipoprotein E (APOE) polymorphisms influenced...
Alzheimer’s disease · Dementia · Mild cognitive impairment Background: The clinical challenge in sub...
Context: Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nov...
ABSTRACT In recent years there have been major advances in the conceptualisation of dementia and cog...
Alzheimer's dementia commonly impacts the health of older adults and lacks any preventative therapy....
r r Abstract: Objective: Identify genetic factors associated with cognitive maintenance in late life...
Alzheimer's disease (AD) is a chronic progressive neurodegenerative disorder characterized by a...